MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric? (MOCA-2)

Centre Francois Baclesse

Status: Completed

Conditions: Neoplasms

Treatments: Other: Passation of neuropsychological test

Study type: Interventional

Funder types: Other

Identifiers

NCT03299855

2017-A01079-44

Details and patient eligibility

About

This study concerns elderly patients with cancer with onco-geriatric assessment.

This study propose to associate the collection of the results with the Mini-Cog and the CODEX with the passing of the MoCA and the MMS tests, as well as a neuropsychological assessment, in order to determine if the patients have cognitive impairments, to evaluate the sensitivity of these 4 screening tests in elderly patients seeking treatment for their cancer. The results of this study will make it possible, where appropriate, to adapt the practice in the context of oncogeriatric assessment.

Enrollment: 104 patients

Sex: All

Ages: 70+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient aged over 70 years
• Patient with cancer (solid tumor or haemopathy) for whom a first line treatment is envisaged (whatever it is). Surgery and radiotherapy are allowed before entry into the study.
• Patient candidate for oncogeriatric assessment
• Patient agree to participate in the study
• Using the French language

Exclusion criteria

• Primary central nervous system or cerebral metastasis
• Evolutionary psychiatric pathology known (e.g. schizophrenia)
• Severe Visual and / or Auditory Impairment
• Patients unable to respond to cognitive tests
• Patient (s) deprived of liberty, under guardianship or curatorship
• Refusal of participation

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: Single Blind